Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L3VV
|
||||
Former ID |
DNC007112
|
||||
Drug Name |
NSC-339583
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528457] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H22N2O5
|
||||
Canonical SMILES |
C1COCCN1CCCNC2=CC(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O
|
||||
InChI |
1S/C21H22N2O5/c24-16-12-15(22-6-3-7-23-8-10-28-11-9-23)21(27)18-17(16)19(25)13-4-1-2-5-14(13)20(18)26/h1-2,4-5,12,22,24,27H,3,6-11H2
|
||||
InChIKey |
RKTZEDQWXDOHSW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | NAD(P)H dehydrogenase [quinone] 1 | Target Info | Inhibitor | [528457] | |
KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | ||||
PathWhiz Pathway | Vitamin K Metabolism | ||||
WikiPathways | Estrogen metabolism | ||||
Oxidative Stress | |||||
Transcriptional activation by NRF2 | |||||
NRF2 pathway | |||||
Nuclear Receptors Meta-Pathway | |||||
Aryl Hydrocarbon Receptor Pathway | |||||
Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
Metabolism of amino acids and derivatives | |||||
Aryl Hydrocarbon Receptor | |||||
Dopamine metabolism | |||||
Arylhydrocarbon receptor (AhR) signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.